Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
cemiplimab治疗转移性皮肤鳞状细胞癌患者的II期研究:固定剂量、基于体重的给药方案的长期疗效的主要分析
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-000775
Rischin, Danny; Migden, Michael R; Lim, Annette M; Schmults, Chrysalyne D; Khushalani, Nikhil I; Hughes, Brett G M; Schadendorf, Dirk; Dunn, Lara A; Hernandez-Aya, Leonel; Chang, Anne Lynn S; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C; Geiger, Jessica L; Gutzmer, Ralf; Alam, Murad; Okoye, Emmanuel; Mathias, Melissa; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G; Guminski, Alexander